Excision of the A1 pulley for Trigger Thumb
Phase-Based Progress Estimates
Effectiveness
Safety
Trigger Thumb+1 More
Excision of the A1 pulley - ProcedureEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial is investigating whether excision or incision of the A1 pulley is more effective for trigger finger surgery, in terms of recurrence rates, pain relief, and patient-reported outcomes.
Eligible Conditions
- Trigger Thumb
- Trigger Finger
Treatment Effectiveness
Effectiveness Progress
Other trials for Trigger Thumb
Study Objectives
2 Primary · 9 Secondary · Reporting Duration: Baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year
Year 1
Change in patients' reported Working status
Change in patients' reported demand of daily activities
Change in patients' reported pain interference subjective score in social activities
Change in patients' reported pain interference subjective score in the day-to-day activities
Change in patients' reported quantity of pain medication pills per day
Change in patients' reported satisfaction
Change in patients' reported side effects from pain medications
Change in the pain score
Change in the range of motion
Changes in the number of participants using pain medication
Recurrent trigger finger after A1 pulley release
Trial Safety
Safety Progress
Other trials for Trigger Thumb
Trial Design
2 Treatment Groups
incision of the A1 pulley in the standard fashion
1 of 2
excision of the A1 pulley
1 of 2
Active Control
Experimental Treatment
500 Total Participants · 2 Treatment Groups
Primary Treatment: Excision of the A1 pulley · No Placebo Group · N/A
excision of the A1 pulley
Procedure
Experimental Group · 1 Intervention: Excision of the A1 pulley · Intervention Types: Procedureincision of the A1 pulley in the standard fashion
Procedure
ActiveComparator Group · 1 Intervention: Incision of the A1 pulley in the standard fashion · Intervention Types: ProcedureTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year
Who is running the clinical trial?
Emory UniversityLead Sponsor
1,501 Previous Clinical Trials
2,677,056 Total Patients Enrolled
Eric Wagner, MD, MSPrincipal InvestigatorEmory University
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments